SPARQL
Query
Update
Search
Quick
Advanced
Co-occurrence
RelFinder
About
Sources
Admin
System Info
Repository Management
Search Configuration
Sources
16870095
Source:
http://linkedlifedata.com/resource/pubmed/id/16870095
Search
Subject
(
51
)
Predicate
Object
All
Download in:
JSON
RDF
N3/Turtle
N-Triples
Switch to
Custom View
Named Graph
All
UniProt
NCBIGene
DrugBank
ClinicalTrials
UMLS
PubMed
Mappings
MentionedEntities
Language
All
English
Español
Português
Français
Deutsch
Русский
日本語
Български
Inference
Explicit and implicit
Explicit only
Implicit only
Statements in which the resource exists as a subject.
Predicate
Object
rdf:type
pubmed:Citation
lifeskim:mentions
umls-concept:C0001807
,
umls-concept:C0003873
,
umls-concept:C0012634
,
umls-concept:C0080103
,
umls-concept:C1138802
pubmed:issue
3
pubmed:dateCreated
2006-7-27
pubmed:abstractText
To analyse the value of the anti-cyclic citrullinated peptide antibody (anti-CCP) in patients with rheumatoid arthritis (RA) as a prognostic factor, as well as its relationship with disease activity.
pubmed:language
eng
pubmed:journal
http://linkedlifedata.com/resource/pubmed/journal/8308521
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Autoantibodies
,
http://linkedlifedata.com/resource/pubmed/chemical/Biological Markers
,
http://linkedlifedata.com/resource/pubmed/chemical/C-Reactive Protein
,
http://linkedlifedata.com/resource/pubmed/chemical/Peptides, Cyclic
,
http://linkedlifedata.com/resource/pubmed/chemical/Rheumatoid Factor
,
http://linkedlifedata.com/resource/pubmed/chemical/cyclic citrullinated peptide
pubmed:status
MEDLINE
pubmed:issn
0392-856X
pubmed:author
pubmed-author:Fito MantecaCC
,
pubmed-author:Gutierrez PoloRR
,
pubmed-author:Ibanez BoschRR
,
pubmed-author:Loza CortinaEE
,
pubmed-author:del Val del AmoNN
pubmed:issnType
Print
pubmed:volume
24
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
281-6
pubmed:meshHeading
pubmed-meshheading:16870095-Arthritis, Rheumatoid
,
pubmed-meshheading:16870095-Arthrography
,
pubmed-meshheading:16870095-Autoantibodies
,
pubmed-meshheading:16870095-Biological Markers
,
pubmed-meshheading:16870095-Blood Sedimentation
,
pubmed-meshheading:16870095-C-Reactive Protein
,
pubmed-meshheading:16870095-Cross-Sectional Studies
,
pubmed-meshheading:16870095-Female
,
pubmed-meshheading:16870095-Health Status
,
pubmed-meshheading:16870095-Humans
,
pubmed-meshheading:16870095-Joints
,
pubmed-meshheading:16870095-Male
,
pubmed-meshheading:16870095-Middle Aged
,
pubmed-meshheading:16870095-Peptides, Cyclic
,
pubmed-meshheading:16870095-Prognosis
,
pubmed-meshheading:16870095-Questionnaires
,
pubmed-meshheading:16870095-Rheumatoid Factor
,
pubmed-meshheading:16870095-Severity of Illness Index
pubmed:articleTitle
Anti-cyclic citrullinated peptide antibody in rheumatoid arthritis: relation with disease aggressiveness.
pubmed:affiliation
Rheumatology Department, Navarra Hospital, Pamplona, Spain. ndelvaldelamo@hotmail.com
pubmed:publicationType
Journal Article